Pregnancy-associated reduction in vascular protein kinase C activity rebounds during inhibition of NO synthesis

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 278, Issue 2 47-2, 2000, Pages

  Kanashiro, Celia A ^a   Cockrell, Kathy L ^a   Alexander, Barbara T ^a   Granger, Joey P ^a   Khalil, Raouf A ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Nitric oxide; Vascular smooth muscle

Indexed keywords

CALPHOSTIN C; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; PHORBOL DIBUTYRATE; PROTEIN KINASE C; STAUROSPORINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; FEMALE; HYPERTENSION; IMMUNOBLOTTING; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; STRESS; VASCULAR SMOOTH MUSCLE;

EID: 0034012138     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.278.2.r295     Document Type: Article

References (39)

1. Alexander, B. T., M. T. Miller, S. Kassab, J. Novak, J. F. Reckelhoff, W. C. Kruckeberg, and J. P. Granger. Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats. Hypertension 33: 435-439, 1999.
2. Barnett, R. L., L. Ruffini, L. Ramsammy, R. Pasmantier, M. M. Friedlaender, and E. P. Nord. cGMP antagonizes angiotensin-mediated phophatidylcholine hydrolysis and C kinase activation in mesangial cells. Am. J. Physiol. Cell Physiol. 268: C376-C381, 1995.
3. Baylis, C., T. Suto, and K. Conrad. Importance of nitric oxide in control of systemic and renal hemodynamics during normal pregnancy: studies in the rat and implications for preeclampsia. Hypertens. Pregnancy 15: 147-169, 1996.
4. Conrad, K. P., and K. A. Vernier. Plasma levels, urinary excretion, and metabolic production of cGMP during gestation in rats. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 257: R847-R853, 1989.
5. Conrad, K. P., G. M. Joffe, H. Kruszyna, R. Kruszyna, L. G. Rochelle, R. P. Smith, J. E. Chavez, and M. D. Mosher. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J. 7: 566-571, 1993.
6. G-monomethyl-L-arginine and nitroarginine potentiate presser responsiveness of vasoconstrictors in conscious rats. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 262: R1137-R1144, 1992.
7. + entry into vascular smooth muscle during NO synthesis inhibition in pregnant rats. Am. J. Physiol Regulatory Integrative Comp. Physiol. 276: R530-R538, 1999.
8. Danthuluri, N. R., and R. C. Deth. Phorbol ester-induced contraction of arterial smooth muscle and inhibition of α-adrenergic response. Biochem. Biophys. Res. Commun. 125: 1103-1109, 1984.
9. Davidge, S. T., and M. K. McLaughlin. Endogenous modulation of the blunted adrenergic responses in resistance-sized mesenteric arteries from the pregnant rat. Am. J. Obstet. Gynecol. 167:1691-1697, 1992.
10. Davison, J. M., and W. Dunlop. Renal hemodynamics and tubular function in normal human pregnancy. Kidney Int. 18: 152-161, 1980.
11. Edwards, D. L., C. P. Arora, D. T. Bui, and L. C. Castro. Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1. Am. J. Obstet. Gynecol. 175: 484-488, 1996.
12. Farley, D. B., and S. P. Ford. Evidence for declining extracellular calcium uptake and protein kinase C activity in uterine arterial smooth muscle during gestation in gilts. Biol. Reprod. 46: 315-321, 1992.
13. Gant, N. F., G. L. Daley, S. Chand, P. J. Whalley, and P. C. MacDonald. A study of angiotensin II pressor response throughout primigravid pregnancy. Am. J. Clin. Invest. 52: 2682-2689, 1973.
14. Gopalakrishna, R., Z. H. Chen, and U. Gundimeda. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J. Biol. Chem. 268: 27180-27185, 1993.
15. Groenedijk, R., J. B. M. J. Trimbos, and H. C. S. Walenburg. Hemodynamic measurements in preeclampsia: preliminary observation. Am. J. Obstet. Gynecol. 150: 232-236, 1984.
16. Hidaka, H., and H. Hagiwara. Pharmacology of the isoquinoline sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase C. Trends Pharmacol. Sci. 8: 162-164, 1987.
17. Jiang, M. J., and K. G. Morgan. Intracellular calcium levels in phorbol ester-induced contractions of vascular smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 253: H1365-H1371, 1987.
18. 2+ entry during coronary artery contraction by vasoactive eicosanoids. Can. J. Physiol. Pharmacol. 76: 1110-1119, 1998.
19. Kanashiro, C. A., and R. A. Khalil. Signal transduction by protein kinase C in mammalian cells. Clin. Exp. Pharmacol. Physiol. 25: 974-985, 1998.
20. Khalil, R. A., J. K. Crews, J. Novak, S. Kassab, and J. P. Granger. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension 31: 1065-1069, 1998.
21. i threshold for translocation of the α-protein kinase C isoform. Am. J. Physiol. Cell Physiol. 266: C1544-C1551, 1994.
22. 2+-independent isoforms of protein kinase C differentially translocate in smooth muscle. Am. J. Physiol. Cell Physiol. 263: C714-C719, 1992.
23. Khalil, R. A., and K. G. Morgan. Phenylephrine-induced translocation of protein kinase C and shortening of two types of vascular cells of the ferret. J. Physiol. 455: 585-599, 1992.
24. Khalil, R. A., and C. van Breemen. Sustained contraction of vascular smooth muscle: calcium influx or C-kinase activation? J. Pharmacol. Exp. Ther. 244: 537-542, 1988.
25. Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159: 548-553, 1989.
26. Lang, D., and M. J. Lewis. Endothelium-derived relaxing factor inhibits the endothelin-1-induced increase in protein kinase C activity in rat aorta. Br. J. Pharmacol. 104: 139-144, 1991.
27. Liou, Y. M, and K. G. Morgan. Redistribution of protein kinase C isoforms in association with vascular hypertrophy of rat aorta. Am. J. Physiol. Cell Physiol. 267: C980-C989, 1994.
28. Magness, R. R., C. R. Rosenfeld, and B. R. Carr. Protein kinase C in uterine and systemic arteries during ovarian cycle and pregnancy. Am. J. Physiol. Endocrinol. Metab. 260: E464-E470, 1991.
29. G-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy induced refractoriness to vasopressor agents. Am. J. Obstet. Gynecol. 166: 1560-1567, 1992.
30. Molnar, M., T. Suto, T. Toth, and F. Hertelendy. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am. J. Obstet. Gynecol. 170: 1458-1466, 1994.
31. Moncada, S., R. M. J. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
32. 2+ sensitivity in norepinephrine-activated vascular smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 259: H2-H8, 1990.
33. Nishizawa, S., S. Yamamoto, T. Yokoyama, and K. Uemura. Dysfunction of nitric oxide induces protein kinase C activation resulting in vasospasm after subarachnoid hemorrhage. Neurol. Res. 19: 553-562, 1997.
34. Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
35. Rasmussen, H., J. Forder, I. Kojima, and A. Scriabine. TPA-induced contraction of isolated rabbit vascular smooth muscle. Biochem. Biophys. Res. Commun. 122: 776-784, 1984.
36. Sauro, M. D., and D. F. Fitzpatrick. Atrial natriuretic peptides inhibit protein kinase C activation in rat aortic smooth muscle. Pept. Res. 3: 138-141, 1990.
37. Shaul, P. W., R. R. Magness, K. H. Muntz, D. DeBeltz, and L. M. Buja. Alpha 1-adrenergic receptors in pulmonary and systemic vascular smooth muscle, alterations with development and pregnancy. Circ. Res. 67: 1193-1200, 1990.
38. Sladek, S. M., R. R. Magness, and K. P. Conrad. Nitric oxide and pregnancy. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 272: R441-R463, 1997.
39. Studer, R. K., F. R. DeRubertis, and P. A. Craven. Nitric oxide suppresses increases in mesangial cell protein kinase C, transforming growth factor beta, and fibronectin synthesis induced by thromboxane. J. Am. Soc. Nephrol. 7: 999-1005, 1996.